Study of MRA in Patients With Rheumatoid Arthritis (RA)

Sponsor
Chugai Pharmaceutical
Study ID
NCT00144651
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.

Key Dates

Start date
Aug 31, 2001
Status verified
Aug 2013
Primary completion
Jun 30, 2009
Completion
Jun 30, 2009

Study Design

Enrollment
135 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 1

Primary Outcome Measure

ACR 20% responder rate compared to the pre-treatment in the preceding study [ Time Frame: throughout study ]

Related Studies